{"id":8269,"date":"2021-12-16T13:19:30","date_gmt":"2021-12-16T18:19:30","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/traiter-cas-52232-67-4-dacetate-de-teriparatide-dapprovisionnement-de-puya-pour-losteoporose\/"},"modified":"2021-12-16T13:19:30","modified_gmt":"2021-12-16T18:19:30","slug":"traiter-cas-52232-67-4-dacetate-de-teriparatide-dapprovisionnement-de-puya-pour-losteoporose","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fr\/product\/traiter-cas-52232-67-4-dacetate-de-teriparatide-dapprovisionnement-de-puya-pour-losteoporose\/","title":{"rendered":"Traiter CAS 52232-67-4 d&#39;ac\u00e9tate de t\u00e9riparatide d&#39;approvisionnement de Puya pour l&#39;ost\u00e9oporose"},"content":{"rendered":"<h2><strong>Traiter CAS 52232-67-4 d&#39;ac\u00e9tate de t\u00e9riparatide d&#39;approvisionnement de Puya pour l&#39;ost\u00e9oporose<\/strong><\/h2>\n<p>Nom du produit\u00a0: Ac\u00e9tate de t\u00e9riparatide<br \/>\nSynonymes\u00a0: HORMONE PARATHYRODE HUMAIN\u00a0: FRAGMENT 1-34\u00a0; HORMONE PARATHYRODE (HUMAIN, 1-34)\u00a0; HORMONE PARATHYRODE (1-34), HUMAINE\u00a0; PTH (1-34) (HUMAIN );PTH (HUMAIN, 1-34);TERIPARATIDE;T\u00e9riparatide ac\u00e9tate;SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF<br \/>\nCAS\u00a0: 52232-67-4<br \/>\nMF\u00a0: C172H278N52O47S2<br \/>\nMW\u00a0: 3890.49792<br \/>\nEINECS\u00a0: 640-978-1&lt; &amp;&gt;Cat\u00e9gories de produits\u00a0:\u00a0D\u00e9riv\u00e9s d&#39;acides amin\u00e9s\u00a0;Endocrinologie et hormones\u00a0;Peptide\u00a0;Hormones\u00a0;Autres prot\u00e9ines\/hormones peptidiques\u00a0;prot\u00e9ines\u00a0;Peptides et prot\u00e9ines de l&#39;hormone parathyro\u00efdienne (PTH)\u00a0;Fragments d&#39;hormone parathyro\u00efdienne\u00a0;Peptides pour la biologie cellulaire\u00a0;Peptides et prot\u00e9ines\u00a0;Divers peptides<br \/>\n Fichier Mol : 52232-67-4.mol<\/p>\n<p>Le t\u00e9riparatide est un produit recombinant repr\u00e9sentant les 34 premiers acides amin\u00e9s de l&#39;hormone parathyro\u00efdienne humaine. Le t\u00e9riparatide augmente la formation osseuse, le taux de remodelage osseux, ainsi que le nombre et l&#39;activit\u00e9 des ost\u00e9oblastes. La masse osseuse et l&#39;architecture sont am\u00e9lior\u00e9es.<br \/>\nLe t\u00e9riparatide est approuv\u00e9 par la FDA pour les femmes et les hommes m\u00e9nopaus\u00e9s qui pr\u00e9sentent un risque \u00e9lev\u00e9 de fracture.<\/p>\n<p> <strong>Ac\u00e9tate de t\u00e9riparatide CAS 52232-67-4 Propri\u00e9t\u00e9s chimiques<\/strong><br \/>\nRTECS SQ7770000&lt; &amp;&gt;temp\u00e9rature de stockage. \u221220\u00b0C<br \/>\nform powder<br \/>\nCAS DataBase Reference 52232-67-4(CAS DataBase Reference)<\/p>\n<p> <strong>Utilisations de l&#39;ac\u00e9tate de t\u00e9riparatide CAS 52232-67-4<\/strong><br \/>\nT\u00e9riparatide est une forme recombinante de la parathyro\u00efde hormone, qui est utilis\u00e9e pour le traitement de l&#39;ost\u00e9oporose chez les hommes et les femmes m\u00e9nopaus\u00e9es. La r\u00e9gion N-terminale poss\u00e8de 34 acides amin\u00e9s, qui sont identiques \u00e0 la r\u00e9gion biologiquement active de la s\u00e9quence de 84 acides amin\u00e9s de l&#39;hormone parathyro\u00efdienne humaine. Il a \u00e9t\u00e9 d\u00e9montr\u00e9 qu&#39;il agit sur les ost\u00e9oblastes pour stimuler la nouvelle croissance osseuse et am\u00e9liorer la densit\u00e9 osseuse.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nom du produit : Ac\u00e9tate de t\u00e9riparatide<br \/>\nCAS : 52232-67-4<br \/>\nMF : C172H278N52O47S2<br \/>\nMW : 3890.49792<br \/>\nEINECS : 640-978-1<br \/>\nMol File : 52232-67-4.mol<\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[469],"product_tag":[1401],"class_list":{"0":"post-8269","1":"product","2":"type-product","3":"status-publish","5":"product_cat-peptide-dosteoporose","6":"product_tag-puya-supply-teriparatide-acetate-cas-52232-67-4-treat-for-osteoporosis-fr","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product\/8269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/comments?post=8269"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media?parent=8269"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_brand?post=8269"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_cat?post=8269"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_tag?post=8269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}